A novel variant in MITF in a child from Yunnan-Guizhou Plateau with autosomal dominant inheritance of nonsyndromic hearing loss : A case report

Deafness and hearing loss may have functional, economic, social and emotional impacts on humans, including the ability of an individual to communicate with others, feelings of isolation and frustration, and health sector costs. The World Health Organization reported that there are 32 million children worldwide with hearing loss. In order to investigate genetic mutations in children of 26 nationalities with hearing loss in Yunnan, Sanger sequencing was employed to screen for mutations in four of the most common pathological genes, including gap junction protein β2 and 3, solute carrier family 26 member 4 and mitochondrial DNA. Whole exome sequencing was used to detect the mutation in the proband of a family in which these four genes were normal. Subsequently, the mutation was identified by Sanger sequencing. The present study reports a novel mutation, c.718C>G; p. (Arg240Gly) in the melanogenesis associated transcription factor gene, in Han people with hearing loss. The results of the present study may provide parents and children an accurate diagnosis, which may allow physicians to how to rehabilitate children's hearing.

Medienart:

E-Artikel

Erscheinungsjahr:

2018

Erschienen:

2018

Enthalten in:

Zur Gesamtaufnahme - volume:17

Enthalten in:

Molecular medicine reports - 17(2018), 4 vom: 01. Apr., Seite 6054-6058

Sprache:

Englisch

Beteiligte Personen:

Zhang, Zhen [VerfasserIn]
Chen, Quan-Dong [VerfasserIn]
Zhao, Li-Ping [VerfasserIn]
Ma, Jing [VerfasserIn]
Zhang, Tie-Song [VerfasserIn]
Pang, Jing-Xue [VerfasserIn]
Li, Yang-Fang [VerfasserIn]
Wang, Mei-Fen [VerfasserIn]
Wang, Ai-Ping [VerfasserIn]
Tang, Li [VerfasserIn]
Li, Li-Jun [VerfasserIn]
He, Wen-Ji [VerfasserIn]
Gu, Huaiyu [VerfasserIn]

Links:

Volltext

Themen:

Case Reports
Children
Hearing loss
Journal Article
MITF protein, human
Melanogenesis associated transcription factor gene
Microphthalmia-Associated Transcription Factor
Novel variant
Yunnan-Guizhou Plateau

Anmerkungen:

Date Completed 30.08.2018

Date Revised 07.12.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.3892/mmr.2018.8627

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM281424225